Effectiveness of Standard Therapy for Acne Vulgaris Based on Clinical Practice Guidelines in Indonesia
Maria Clarissa Wiraputranto,Irma Bernadette Sitohang,Adhimukti Sampurna,Muhammad Ilyas
DOI: https://doi.org/10.2147/ccid.s469143
2024-09-29
Clinical Cosmetic and Investigational Dermatology
Abstract:Maria Clarissa Wiraputranto, 1 Irma Bernadette S Sitohang, 1 Adhimukti Tathyahita Sampurna, 1 Muhammad Ilyas 2 1 Department of Dermatology and Venereology, Faculty of Medicine Universitas Indonesia, Dr. Cipto Mangunkusumo National Central General Hospital, Jakarta, Indonesia; 2 Department of Community Medicine, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia Correspondence: Irma Bernadette S Sitohang, Department of Dermatology and Venereology, Faculty of Medicine Universitas Indonesia, Dr. Cipto Mangunkusumo National Central General Hospital, Jakarta, Indonesia, 10430, Tel +62818130761, Email Purpose: To evaluate the effectiveness of standard therapy for acne vulgaris based on Indonesian guidelines. Patients and Methods: New patients with acne vulgaris at Dr. Cipto Mangunkusumo National Central General Hospital, the national referral center in Indonesia, who met the criteria were included in this study. Patients were treated with standard therapy for acne vulgaris based on the 2017 guidelines of Dr. Cipto Mangunkusumo Hospital, depending on severity. Changes in the number of non-inflammatory, inflammatory, and total lesions and the proportion of acne severity after three months of therapy were analyzed retrospectively. Results: Among the 131 subjects, 63.4% had moderate acne; 20.6% had mild acne, and 16% had severe acne at baseline. Most patients (29 (22.2%)) received a combination of retinoic acid, benzoyl peroxide, and topical or oral antibiotics. Standard therapies reduced the median of non-inflammatory (25 (5– 135) vs 8 (0– 53)), inflammatory (10 (0– 93) vs 2 (0– 22)), and total lesions (41 (10– 160) vs 10 (1– 71)) at week 12 (all p < 0.001). The proportion of acne severity differed significantly after three months, with an increasing proportion of mild acne (20.6% vs 93.1%) and a decreasing percentage of moderate and severe acne (moderate = 63.6% vs 6.1%; severe, 16% vs 0.8%; p < 0.001). Conclusion: Standard therapy for acne vulgaris based on the clinical practice guidelines in Indonesia improved acne lesions and severity after 12 weeks. These results support the implementation of national guidelines for acne management in Indonesia, with the practice of improving antimicrobial stewardship. Keywords: acne vulgaris, clinical practice guideline, therapy, Indonesia, effectiveness Acne vulgaris (AV) is a prevalent chronic inflammatory disorder of the pilosebaceous unit affecting all ages, especially teenagers and young adults, leading to depression and anxiety in more severe cases. 1 It is the third most frequent dermatological cases at the Central and Regional General Hospital in Indonesia. 2 The incidence of AV constituted about 46% of the total new cases at Dr. Cipto Mangunkusumo National Central General Hospital's Cosmetic Dermatology clinic, with over 50% of moderate-to-severe acne. Effective and timely treatment of acne is needed to hasten skin resolution, prevent the formation of new acne and permanent scars, and alleviate the associated psychosocial burden. 1–3 AV management has been challenging because of various diagnostic parameters and treatment options globally accommodating each nation's condition. 3,4 Several acne guidelines are available in Indonesia, such as the consensus of the Indonesian Acne Expert Meeting (IAEM) in 2015 2 , clinical practice guidelines (CPGs) of the Indonesian Society of Dermatology and Venereology (INSDV) 5 and Dr. Cipto Mangunkusumo Hospital 6 in 2017, which have similarities in the recommended treatment choices. These national guidelines emanate from the best available evidence and relevant international guidelines with some adjustments; however. 3 To the best of our knowledge, there are no data on the effectiveness of standard therapy for AV based on the national guidelines to date. This study analyzed medical records from 2017 to 2019, as there was a COVID-19 pandemic from 2020 to 2021, thus hindering routine follow-up. The AV guideline in this research referred to the one by Dr. Cipto Mangunkusumo Hospital 2017 in line with the date of outpatient visits, for which therapy was based on this CPG. This paper presents the clinical outcomes of standard regimens in the national guidelines. This retrospective observational study was conducted using medical records from a national referral hospital in Indonesia. Data of new patients diagnosed with AV in the dermatology outpatient clinic between 2017 and 2019 were extracted. Cases were selected based on the inclusion and exclusion criteria of the total sampling technique. The minimum sample size was determined using the following formula: n = ( × p × q)/d 2 , where z = 1 -Abstract Truncated-
dermatology